Download presentation
Presentation is loading. Please wait.
Published bySucianty Hermanto Modified over 5 years ago
1
Segmentectomy Is Equivalent to Lobectomy in Hypermetabolic Clinical Stage IA Lung Adenocarcinomas
Mohamed K. Kamel, MD, Mohamed Rahouma, MD, Benjamin Lee, MD, Sebron W. Harrison, MD, Brendon M. Stiles, MD, Nasser K. Altorki, MD, Jeffrey L. Port, MD The Annals of Thoracic Surgery Volume 107, Issue 1, Pages (January 2019) DOI: /j.athoracsur Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 CONSORT (Consolidated Standards Of Reporting Trials) diagram detailing selection of study groups. (PET = positron emission tomography; pt = patient; SUVmax = maximum standard uptake value.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Recurrence-free survival (RFS) of patients undergoing lobectomy and anatomic segmentectomy in the matched groups. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 Cancer-specific survival (CSS) of patients undergoing lobectomy and anatomic segmentectomy in the matched groups. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.